{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:34:19Z","timestamp":1790037259494,"version":"4.0.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T00:00:00Z","timestamp":1238630400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0004897","type":"journal-article","created":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T23:12:52Z","timestamp":1238627572000},"page":"e4897","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Deciphering von Hippel-Lindau (VHL\/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations"],"prefix":"10.1371","volume":"4","author":[{"given":"H.-C. Jennifer","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Adem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Ylaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Lorang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Pechhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Harlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Lubensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Marston","family":"Linehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Libutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0025-6196(11)65031-3","article-title":"von Hippel-Lindau disease.","volume":"75","author":"V Couch","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene.","volume":"260","author":"F Latif","year":"1993","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/humu.1380050109","article-title":"Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.","volume":"5","author":"F Chen","year":"1995","journal-title":"Hum Mutat"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s004390050206","article-title":"Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe.","volume":"98","author":"D Glavac","year":"1996","journal-title":"Hum Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jama.1995.03520310062031","article-title":"Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.","volume":"273","author":"WM Linehan","year":"1995","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/hmg\/10.7.763","article-title":"Genotype-phenotype correlation in von Hippel-Lindau syndrome.","volume":"10","author":"CA Friedrich","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","article-title":"von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.","volume":"10","author":"MA Hoffman","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64038-2","article-title":"Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.","volume":"158","author":"S Ivanov","year":"2001","journal-title":"Am J Pathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"40346","DOI":"10.1074\/jbc.M105391200","article-title":"The von Hippel-Lindau protein interacts with heteronuclear ribonucleoprotein a2 and regulates its expression.","volume":"276","author":"PA Pioli","year":"2001","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.93.20.10595","article-title":"Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.","volume":"93","author":"O Iliopoulos","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.","volume":"399","author":"PH Maxwell","year":"1999","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/hmg\/10.10.1029","article-title":"Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.","volume":"10","author":"SC Clifford","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9440(10)65541-1","article-title":"Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF\/HIF-2alpha.","volume":"153","author":"I Flamme","year":"1998","journal-title":"Am J Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/bbrc.1999.1767","article-title":"An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association.","volume":"266","author":"HT Cohen","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1128\/MCB.17.9.5629","article-title":"The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.","volume":"17","author":"D Mukhopadhyay","year":"1997","journal-title":"Mol Cell Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"27509","DOI":"10.1074\/jbc.272.44.27509","article-title":"The von Hippel-Lindau gene product inhibits vascular permeability factor\/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways.","volume":"272","author":"S Pal","year":"1997","journal-title":"J Biol Chem"},{"key":"ref17","first-page":"2929","article-title":"Role of the von Hippel-Lindau tumor suppressor gene in the formation of beta1-integrin fibrillar adhesions.","volume":"62","author":"MA Esteban-Barragan","year":"2002","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ncb899","article-title":"Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.","volume":"5","author":"A Hergovich","year":"2003","journal-title":"Nat Cell Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","article-title":"The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix.","volume":"1","author":"M Ohh","year":"1998","journal-title":"Mol Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1128\/MCB.26.7.2519-2530.2006","article-title":"pVHL function is essential for endothelial extracellular matrix deposition.","volume":"26","author":"N Tang","year":"2006","journal-title":"Mol Cell Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF03401583","article-title":"Expression of the Von Hippel-Lindau tumor suppressor gene, VHL, in human fetal kidney and during mouse embryogenesis.","volume":"1","author":"PM Kessler","year":"1995","journal-title":"Mol Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/hmg\/5.5.639","article-title":"Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis.","volume":"5","author":"FM Richards","year":"1996","journal-title":"Hum Mol Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1073\/pnas.94.17.9102","article-title":"Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice.","volume":"94","author":"JR Gnarra","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1073\/pnas.98.4.1583","article-title":"Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.","volume":"98","author":"VH Haase","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","first-page":"5320","article-title":"Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene.","volume":"63","author":"W Ma","year":"2003","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9038","DOI":"10.1128\/MCB.24.20.9038-9047.2004","article-title":"Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes.","volume":"24","author":"MP Biju","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1242\/dev.01138","article-title":"Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development.","volume":"131","author":"D Pfander","year":"2004","journal-title":"Development"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-05-3241","article-title":"Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.","volume":"66","author":"EB Rankin","year":"2006","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2214\/ajr.162.5.8165988","article-title":"Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings.","volume":"162","author":"DM Hough","year":"1994","journal-title":"AJR Am J Roentgenol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0016-5085(91)90026-H","article-title":"Pancreatic lesions in the von Hippel-Lindau syndrome.","volume":"101","author":"HP Neumann","year":"1991","journal-title":"Gastroenterology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2214\/ajr.155.3.1974734","article-title":"Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias.","volume":"155","author":"LA Binkovitz","year":"1990","journal-title":"AJR Am J Roentgenol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1067\/msy.1998.91823","article-title":"Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations.","volume":"124","author":"SK Libutti","year":"1998","journal-title":"Surgery"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0002-9440(10)65563-0","article-title":"Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.","volume":"153","author":"IA Lubensky","year":"1998","journal-title":"Am J Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/dbio.1999.9209","article-title":"Z\/AP, a double reporter for cre-mediated recombination.","volume":"208","author":"CG Lobe","year":"1999","journal-title":"Dev Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7","article-title":"Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas.","volume":"26","author":"M Gannon","year":"2000","journal-title":"Genesis"},{"key":"ref36","first-page":"341","article-title":"von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase.","volume":"30","author":"SK Park","year":"2007","journal-title":"Int J Oncol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1242\/dev.129.10.2447","article-title":"Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors.","volume":"129","author":"G Gu","year":"2002","journal-title":"Development"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0002-9440(10)64799-2","article-title":"Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients.","volume":"157","author":"VH Mohr","year":"2000","journal-title":"Am J Pathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1128\/MCB.25.13.5675-5686.2005","article-title":"Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.","volume":"25","author":"RR Raval","year":"2005","journal-title":"Mol Cell Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1385\/ENDO:19:3:267","article-title":"Pancreatic cell lineage analyses in mice.","volume":"19","author":"PL Herrera","year":"2002","journal-title":"Endocrine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00000478-198804000-00001","article-title":"Microcystic adenoma (serous cystadenoma) of the pancreas. A study of 14 cases with immunohistochemical and electron-microscopic correlation.","volume":"12","author":"LC Alpert","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00000478-198606000-00001","article-title":"Microcystic adenomas (serous cystadenomas) of pancreas. A clinicopathologic investigation of eight cases with immunohistochemical and ultrastructural studies.","volume":"10","author":"SD Shorten","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2559.1983.tb02277.x","article-title":"Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases.","volume":"7","author":"T Morohoshi","year":"1983","journal-title":"Histopathology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ajcp\/84.1.114","article-title":"Microcystic adenoma of the pancreas with myoepithelial cells. A hitherto undescribed morphologic feature.","volume":"84","author":"A Nyongo","year":"1985","journal-title":"Am J Clin Pathol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.surg.2007.09.012","article-title":"Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).","volume":"142","author":"JA Blansfield","year":"2007","journal-title":"Surgery"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1371\/journal.pmed.0040060","article-title":"von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.","volume":"4","author":"DM Park","year":"2007","journal-title":"PLoS Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/0008-5472.CAN-05-2560","article-title":"Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis.","volume":"66","author":"G Kurban","year":"2006","journal-title":"Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/labinvest.3700431","article-title":"Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis.","volume":"86","author":"SB Hong","year":"2006","journal-title":"Lab Invest"},{"key":"ref49","first-page":"H2547","article-title":"Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding.","volume":"271","author":"G Thurston","year":"1996","journal-title":"Am J Physiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1677\/ERC-07-0191","article-title":"Parathyroid tumor development involves deregulation of homeobox genes.","volume":"15","author":"HC Shen","year":"2008","journal-title":"Endocr Relat Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0004897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T21:41:18Z","timestamp":1633297278000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0004897"}},"subtitle":[],"editor":[{"given":"David R.","family":"Beier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,2]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0004897","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,2]]}}}